Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

December 2022

News

OCPC: In Session
12/05/2022
Winston Wong, PharmD, Editor-in-Chief
Winston Wong, PharmD, Editor-in-Chief, presents the highlights of the 2022 Clinical Pathways Benchmark Survey results, as presented as part of the Oncology Clinical Pathways Congress in Boston in October.
Winston Wong, PharmD, Editor-in-Chief, presents the highlights of the 2022 Clinical Pathways Benchmark Survey results, as presented as part of the Oncology Clinical Pathways Congress in Boston in October.
Winston Wong, PharmD,...
12/05/2022
Journal of Clinical Pathways

Department

OCPC: In Session
12/05/2022
Winston Wong, PharmD, Editor-in-Chief
Winston Wong, PharmD, Editor-in-Chief, presents the highlights of the 2022 Clinical Pathways Benchmark Survey results, as presented as part of the Oncology Clinical Pathways Congress in Boston in October.
Winston Wong, PharmD, Editor-in-Chief, presents the highlights of the 2022 Clinical Pathways Benchmark Survey results, as presented as part of the Oncology Clinical Pathways Congress in Boston in October.
Winston Wong, PharmD,...
12/05/2022
Journal of Clinical Pathways

Feature

Research Reports
12/05/2022
Theresa Schmidt, MA
Tom Valuck, MD, JD
Jacqlyn Riposo, MBA
Palak Patel, MHA
Brittany Perkins, MPH
Kimberly Westrich, MA
Robert W Dubois, MD, PhD
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...
The authors summarize evidence...
12/05/2022
Journal of Clinical Pathways

Column

Editor's Page
12/05/2022
Winston Wong, PharmD, Editor-in-Chief
Winston Wong, PharmD, Editor-in-Chief, outlines the December issue while suggesting that the future of clinical pathways would include a transformation of what we know as a “clinical pathway” today into a “care pathway” tomorrow.
Winston Wong, PharmD, Editor-in-Chief, outlines the December issue while suggesting that the future of clinical pathways would include a transformation of what we know as a “clinical pathway” today into a “care pathway” tomorrow.
Winston Wong, PharmD,...
12/05/2022
Journal of Clinical Pathways
Feature Interview
12/05/2022
The Journal of Clinical Pathways sat down with Anne Hubbard, Director of Health Policy at the American Society for Radiation Oncology, to discuss the Radiation Oncology Model, the impact of the decision to delay the payment model, and ASTRO’s...
The Journal of Clinical Pathways sat down with Anne Hubbard, Director of Health Policy at the American Society for Radiation Oncology, to discuss the Radiation Oncology Model, the impact of the decision to delay the payment model, and ASTRO’s...
The Journal of Clinical Pathways...
12/05/2022
Journal of Clinical Pathways
Trending From ACCC
12/05/2022
Association of Community Cancer Centers
To better facilitate education and adoption of new advancements, the Association of Community Cancer Centers created the Oncology Practice Transformation and Integration Center program that establishes a network of multidisciplinary...
To better facilitate education and adoption of new advancements, the Association of Community Cancer Centers created the Oncology Practice Transformation and Integration Center program that establishes a network of multidisciplinary...
To better facilitate education...
12/05/2022
Journal of Clinical Pathways
Pharma Insights
12/05/2022
Jacquelyn W Chou, MPP, MPL
Alexandria Portelli, MPH
Andrew Cournoyer, RPh, MBA
The authors discuss how a strategic HEOR evidence-generation plan that comprehensively communicates the value of a new drug helps to ensure that patients have access to innovative drugs and health care stakeholders have access to data to...
The authors discuss how a strategic HEOR evidence-generation plan that comprehensively communicates the value of a new drug helps to ensure that patients have access to innovative drugs and health care stakeholders have access to data to...
The authors discuss how a...
12/05/2022
Journal of Clinical Pathways
PATIENT PERSPECTIVE
12/05/2022
Alan J Balch, PhD, MSc
Rebekah SM Angove, PhD
Kathleen D Gallagher, MPH
Alan Balch and colleagues explain the efforts and standards that the Patient Advocate Foundation and the National Patient Advocate Foundation set out to establish for determining the extent to which a decision support tool could be considered...
Alan Balch and colleagues explain the efforts and standards that the Patient Advocate Foundation and the National Patient Advocate Foundation set out to establish for determining the extent to which a decision support tool could be considered...
Alan Balch and colleagues...
12/05/2022
Journal of Clinical Pathways

Insights

Podcasts
12/05/2022

An interview with Dan Rhodes, CEO, Strata Oncology

An interview with Dan Rhodes, CEO, St...
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes,...
12/05/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement